ARDELYX, INC. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
ARDELYX, INC. (ARDX) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 0 shares as of 2014-12-31, per its 10-K filed 2015-03-05.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2015-03-05
- 2014-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 0.00 shares.
- 2014-09-30: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 133.84K shares.
- 2014-06-30: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 193.45K shares.
- 2013-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 286.22K shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased |
|---|---|
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-05 |
| 2014-09-30 | 133.84K shares 10-Q · filed 2014-11-07 |
| 2014-06-30 | 193.45K shares 10-Q · filed 2014-08-08 |
| 2013-12-31 | 286.22K shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |